Territorial Availability: Available through Bertin Technologies only in France
- Correlated keywords
- ligand PPAR? PPARg PPAR-? PPAR-g antidiabetic anti-diabetic diabetes peroxisome nuclear receptor proliferator-activated
- Product Overview:
The Cayman PPAR? Ligand Pack contains a combination of frequently used ligands for the nuclear PPAR?. Each kit contains Ciglitazone, the first characterized member of the thiazolidinedione (TZD) class that binds to the PPAR? ligand-binding domain with an EC50 value of 3.0 µM.{7575,10122} Rosiglitazone, a key reference TZD also called BRL 49653, its more potent structural homolog MCC-555, and PPAR?-1-selective pioglitazone are other PPAR? agonists provided. Also included is Troglitazone (Resulin™), another TZD; it was withdrawn from human therapeutic use due to hepatotoxicity.{8555} Also in this assortment is 15-deoxy-?12,14-Prostaglandin J2, a potent PPAR? ligand derived from PGD2. The actions of all of these compounds can be antagonized by the selective PPAR? antagonist, GW 9662, which is also in the kit.{9318}
Cayman Chemical’s mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.